York 10-Q: $749.7M Goodwill Impairment, 2027 Revenue Covenant Doubt
YSS is trading near its 52-week low of $5.26 (12% above the low).
Summary
York's Q3 10-Q details a $749.7 million goodwill impairment and flags uncertainty over meeting its 2027 minimum revenue covenant, alongside an unremediated revenue-recognition material weakness and two IPO-related securities suits.
Key Events · Earnings and Guidance · YSS
-
$749.7M Goodwill Impairment
York wrote down $749.7 million of goodwill in Q3 2026, cutting the balance from $674.3 million to $322.5 million, after lowering its 2026 revenue forecast and losing visibility on awards beyond 2026 under the government's IDIQ shift.
-
2027 Revenue Covenant in Doubt
Management states there is uncertainty about satisfying the minimum revenue covenant in 2027, which steps up to $426.9 million for the March 31, 2027 test; the company was in compliance as of September 30, 2026.
-
Q3 Revenue Down 7%
Revenue fell to $84.2 million from $90.8 million a year earlier and gross margin compressed to 18% from 22%, while the net loss reached $807.4 million on the impairment.
-
Material Weakness Unremediated
The revenue-recognition material weakness disclosed in the 2025 10-K remains unremediated; management concluded disclosure controls were not effective as of September 30, 2026.
Analysis · YSS · Manufacturing
The Q3 numbers were already out on November 12, but the 10-Q fills in what drove them: a $749.7 million non-cash goodwill write-down that cut goodwill from $674.3 million to $322.5 million after the company lowered its 2026 revenue forecast and could not estimate awards beyond 2026 under the government's shift to IDIQ contracting. More concerning is the explicit statement that management sees uncertainty in meeting the minimum revenue covenant in 2027 — $426.9 million for the March 31, 2027 test — which depends on winning task orders that have not yet materialized. Cash of $308.9 million against $147.2 million of term debt gives room to repay if the covenant is accelerated, but that would drain the balance sheet. The filing also confirms the revenue-recognition material weakness is still unremediated and details two securities class actions over the IPO.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, YSS was trading at $5.89 on NYSE in the Manufacturing sector, with a market capitalization of approximately $906.6M. The 52-week trading range was $5.26 to $44.54. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.